Palladium103QualityChecker

Palladium-103

radiopharmaceuticals QC URS & FS input.csv output.json radiochemical purity radionuclidic purity SPECT
Open selection

Utility description: Palladium-103

Palladium-103 Quality Checker — Palladium-103 for Brachytherapy
ℹ️ Utility checks critical parameters of Palladium-103:
• Radionuclidic purity (≥99.9%)
• Palladium-109 impurity (≤0.1%)
• Chemical purity (≥99.0%)
• Radiochemical purity (≥98.0%)
• pH, endotoxins, sterility
⚠️ CRITICAL: Pd-109 impurity >0.1% → beta emission unpredictably alters dose!
Sterility failure → high risk of infection during permanent implantation!
Usage:
Palladium103QualityChecker.exe → demo mode (console output)
Palladium103QualityChecker.exe input.csv output.json → evaluate your data
Input format:
BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Palladium109ImpurityPercent,Silver103ImpurityPercent,RadiochemicalPurityPercent,ChemicalPurityPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType
Example (sterility: 0=sterile, 1=contaminated):
Pd103-SEED-2026-001,400.0,99.95,0.02,0.01,99.5,99.9,3.0,10.0,0,1,Brachytherapy_Seeds
Supported product types:
• Brachytherapy_Seeds — permanent implantation for prostate cancer treatment (Low Dose Rate - LDR)
• Research_Solution — research purposes
— WHY IS THIS NEEDED?
Palladium-103 is a key isotope for brachytherapy:
• Half-life: 16.99 days
• Emission: Characteristic X-rays (20-23 keV) and gamma rays (41 keV)
• Used in titanium seeds for permanent placement in the prostate gland
• Advantages: Rapid dose fall-off, less shielding required for staff compared to I-125
⚠️ CRITICAL:
• Palladium-109 impurity ≤0.1% — Pd-109 (T½=13.5 h) is a beta emitter. Its presence is unacceptable as beta particles have a short range but create a high local dose on the source surface, potentially leading to necrosis of the urethra or rectum, and distorting the calculated dose.
• Chemical purity ≥99.0% — Presence of target material (e.g., Rhodium-103, if produced via Rh-103(p,n)) or other metals can disrupt the coating process on the graphite rod inside the seed, affecting activity uniformity.
• Sterility and endotoxins — Critical as seeds are implanted directly into patient tissues.
• Radiochemical purity — Determines the form of palladium (usually chloride or metal coating), important for the seed manufacturing process.
Key features:
• Control of beta-emitting Pd-109 impurity (critical for tissue safety)
• Assessment of chemical purity (affects coating quality)
• Sterility and endotoxin check for implantable devices
• Support for ASTM F2366 standards for Pd-103 seeds
Critical parameters:
• Radionuclidic purity: ≥99.9%
• Palladium-109 impurity: ≤0.1%
• Chemical purity: ≥99.0%
• Radiochemical purity: ≥98.0%
• pH: 1.0–7.0 (depends on form)
• Endotoxins: ≤175 EU/vial
• Sterility: no microbial growth
• Heavy metals: ≤10 ppm
💡 Usage tips:
Pd-109 is controlled by gamma spectrometry (search for peaks characteristic of Pd-109/Ag-109m)
Chemical purity is determined by ICP-MS or AAS
Seed activity is calibrated considering the 17-day half-life
In seed production, it is important to control the uniformity of Pd-103 distribution on the carrier
⚠️ Note: Unlike diagnostic radiopharmaceuticals, Pd-103 is used in solid form (seeds). Therefore, quality control often includes not only the precursor solution but also finished product parameters (leak tightness, uniformity). This utility focuses on the radiochemical and radionuclidic parameters of the source material/solution.

input.csv

BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Palladium109ImpurityPercent,Silver103ImpurityPercent,RadiochemicalPurityPercent,ChemicalPurityPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType
Pd103-SEED-2026-001,400.0,99.95,0.02,0.01,99.5,99.9,3.0,10.0,0,1,Brachytherapy_Seeds
Pd103-SEED-2026-002,380.0,99.80,0.15,0.05,98.0,99.5,3.5,180.0,0,8,Brachytherapy_Seeds
Pd103-RES-2026-001,500.0,99.99,0.005,0.001,99.9,99.99,2.0,5.0,0,0.5,Research_Solution

URS & FS — User Requirements and Functional Specification

This document describes the controlled interface and behaviour of Palladium103QualityChecker for Palladium-103.

Domain limits and critical parameters

Key fragments from the source description are shown below. Before production use, limits must be verified against the approved specification, registration dossier and local SOPs.
  • ℹ️ Utility checks critical parameters of Palladium-103:
  • • Radionuclidic purity (≥99.9%)
  • • Palladium-109 impurity (≤0.1%)
  • • Chemical purity (≥99.0%)
  • • Radiochemical purity (≥98.0%)
  • • pH, endotoxins, sterility
  • ⚠️ CRITICAL: Pd-109 impurity >0.1% → beta emission unpredictably alters dose!
  • Sterility failure → high risk of infection during permanent implantation!
  • BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Palladium109ImpurityPercent,Silver103ImpurityPercent,RadiochemicalPurityPercent,ChemicalPurityPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType
  • Example (sterility: 0=sterile, 1=contaminated):
  • ⚠️ CRITICAL:
  • • Chemical purity ≥99.0% — Presence of target material (e.g., Rhodium-103, if produced via Rh-103(p,n)) or other metals can disrupt the coating process on the graphite rod inside the seed, affecting activity uniformity.
  • • Sterility and endotoxins — Critical as seeds are implanted directly into patient tissues.
  • • Radiochemical purity — Determines the form of palladium (usually chloride or metal coating), important for the seed manufacturing process.

URS — User Requirements Specification

IDRequirementCriticalityAcceptance criterion
URS-001The utility shall accept an input.csv file with the exact headers defined in the data contract.HighThe file is processed without manual header editing.
URS-002The utility shall perform deterministic QC evaluation for Palladium-103 using input values, approved limits and domain rules.HighEach input row receives a PASS / WARNING / FAIL status.
URS-003The utility shall validate mandatory fields, data types, numeric ranges, units and pharmaceutical/radiochemical plausibility.HighSchema and conversion errors are explicitly reported.
URS-004The utility shall identify critical deviations related to radionuclidic purity, radiochemical purity, free radionuclide, impurities, pH, endotoxins and sterility when such fields are present.HighA critical deviation causes FAIL or a separate critical finding.
URS-005The utility shall generate output.json with machine-readable results, source values, warnings and failures.HighJSON is suitable for LIMS/ELN/MES integration and QA/QC review.
URS-006The utility shall not use machine learning to decide conformance.MediumThe result is based on explicit rules, thresholds and input values.
URS-007The utility shall preserve traceability between batch number, input values, applied rules and final status.HighThe output contains the batch identifier and the list of checked parameters.
URS-008The documentation shall support IQ/OQ preparation and inspection discussion with FDA/EMA/Roszdravnadzor or local regulators.MediumURS & FS, input.csv/output.json contract and test scenarios are supplied with the utility.

input.csv contract

#FieldTypeSamplePurpose
1BatchNumberstringPd103-SEED-2026-001Batch or lot identifier used for traceability.
2TotalActivityMBqdecimal400.0Radioactivity value used for release, decay or dose-related assessment.
3RadionuclidicPurityPercentstring99.95Radionuclidic purity; a critical radiation-safety and impurity parameter.
4Palladium109ImpurityPercentstring0.02Controlled impurity or residual material.
5Silver103ImpurityPercentstring0.01Controlled impurity or residual material.
6RadiochemicalPurityPercentstring99.5Radiochemical purity; confirms the labelled chemical form and binding quality.
7ChemicalPurityPercentstring99.9Controlled input parameter used by the deterministic QC rules.
8pHdecimal3.0Solution pH; relevant for stability, compatibility and administration.
9EndotoxinsEUdecimal10.0Bacterial endotoxins; critical for parenteral administration.
10SterilityTestflag / boolean0Sterility result; critical release parameter.
11HeavyMetalsPPMdecimal1Elemental impurity / metal residue parameter.
12ProductTypestringBrachytherapy_SeedsControlled input parameter used by the deterministic QC rules.
BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Palladium109ImpurityPercent,Silver103ImpurityPercent,RadiochemicalPurityPercent,ChemicalPurityPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType
Pd103-SEED-2026-001,400.0,99.95,0.02,0.01,99.5,99.9,3.0,10.0,0,1,Brachytherapy_Seeds
Pd103-SEED-2026-002,380.0,99.80,0.15,0.05,98.0,99.5,3.5,180.0,0,8,Brachytherapy_Seeds
Pd103-RES-2026-001,500.0,99.99,0.005,0.001,99.9,99.99,2.0,5.0,0,0.5,Research_Solution

FS — Functional Specification

IDFunctionImplementation
FS-001CSV importRead input.csv in UTF-8/CSV-compatible format and validate the header and expected columns.
FS-002Schema validationCheck mandatory fields and column count; report unknown or missing key fields.
FS-003Type conversionConvert numeric, flag and text values; invalid formats are recorded as row-level errors.
FS-004Domain rule engineApply domain rules for Palladium-103, including critical limits from the utility description and approved specification.
FS-005Status aggregationProduce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance.
FS-006JSON exportWrite output.json with detailed checks, source values, warnings, failures and critical findings.
FS-007Audit supportKeep the result structure suitable for review, deviation investigation, calculation reproduction and IQ/OQ preparation.
FS-008Integration contractSupport the production scenario: LIMS/ELN/MES creates input.csv, the utility returns output.json, the portal displays description and documentation.

Example output.json

{
  "utilityId": "palladium103-quality-checker",
  "api": "Palladium-103",
  "overallStatus": "PASS|WARNING|FAIL",
  "sourceFile": "input.csv",
  "checks": [
    {
      "parameter": "BatchNumber",
      "value": "Pd103-SEED-2026-001",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "TotalActivityMBq",
      "value": "400.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "RadionuclidicPurityPercent",
      "value": "99.95",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Palladium109ImpurityPercent",
      "value": "0.02",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Silver103ImpurityPercent",
      "value": "0.01",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "RadiochemicalPurityPercent",
      "value": "99.5",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "ChemicalPurityPercent",
      "value": "99.9",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "pH",
      "value": "3.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    }
  ],
  "criticalFindings": []
}

OQ/PQ test scenarios

IDScenarioExpected result
OQ-001Valid sample rowPASS or acceptable WARNING according to the rules.
OQ-002Mandatory column missingSchema error or FAIL.
OQ-003Non-numeric value in numeric fieldType-conversion error.
OQ-004Critical parameter outside limitFAIL and critical finding.
PQ-001User real batch/lotReviewed result with input.csv and output.json retained.

QA/QC and change control

  • Do not rename columns without updating the validator and test set.
  • Retain input.csv, output.json, executable version and checksum.
  • Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
  • Critical radiopharmaceutical limits must be verified against the approved specification and local SOPs.

Included in packages

Andrology QC Suite

QC package for andrology: androgens, erectile-dysfunction medicines, BPH/prostate products, fertility and related hormonal checks.

Open

PetRad3: expanded PET/SPECT and radiopharmaceutical QC package

A curated suite for PET/SPECT radiopharmaceuticals, generator and cyclotron radionuclides, labelled compounds, radiochemical purity, breakthrough, sterility and endotoxin control.

Open

Radiology QC Suite

QC package for radiology and diagnostic imaging: radiopharmaceuticals, PET/SPECT, contrast media, iodinated and gadolinium products, plus particle, sterility and endotoxin checks.

Open

RPH organ/system: lymphatic, infection and inflammation

Sentinel node, lymphoscintigraphy, nanocolloid, labelled leukocytes, granulocyte and inflammatory imaging.

Open

RPH organ/system: oncology and theranostics

Tumour imaging, PSMA/FAPI/receptor tracers, immuno-PET, targeted radionuclide therapy and radioembolization.

Open

RPH use case: generators, isotope purity and starting radionuclides

Control of generator eluate, breakthrough, radionuclidic purity, isotope mix, carrier/free radionuclides and starting radionuclides before labeling.

Open

RPH workflow: generators and isotope purity

Generator eluate, breakthrough, radionuclidic purity, isotope mix and starting radionuclides.

Open

RPH workflow: instruments, devices and radiation safety

PET/gamma-camera state, calibration, detector QC, energy window, TOF, shielding and radiation safety.

Open

RPH workflow: product release QC

Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.

Open

RPH: combined radiopharmaceutical QC package

RPH combines PetRad, PetRad2 and PetRad3 into one umbrella package for PET/SPECT, therapeutic radionuclides, generators, labelled compounds, decay calculations, sterility, endotoxins and radiochemical/radionuclidic purity.

Open

Urology QC Suite

QC package for urology: BPH, urolithiasis, overactive bladder, urinary-tract infection medicines and supporting antimicrobial QC checks.

Open